These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22751601)

  • 1. Screening and monitoring of latent tubercular infection in patients taking tumor necrosis factor-α blockers for psoriatic arthritis.
    Sanduzzi A; Bocchino M; Atteno M; Costa L; Ponticiello A; Matarese A; Spanò A; Bruner V; Peluso R; Aquino MM; Del Puente A; Scarpa R
    J Rheumatol Suppl; 2012 Jul; 89():82-5. PubMed ID: 22751601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of latent tuberculosis infection (LTBI) before anti-TNF-alpha treatment--the tuberculin skin test is useful.
    Goujon C; Nosbaum A; Bensaid B; Rozières A; Nicolas JF; Bérard F
    Eur J Dermatol; 2012; 22(5):701-2. PubMed ID: 23032063
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
    Hsia EC; Schluger N; Cush JJ; Chaisson RE; Matteson EL; Xu S; Beutler A; Doyle MK; Hsu B; Rahman MU
    Arthritis Rheum; 2012 Jul; 64(7):2068-77. PubMed ID: 22238071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.
    Mariette X; Baron G; Tubach F; Lioté F; Combe B; Miceli-Richard C; Flipo RM; Goupille P; Allez M; Salmon D; Emilie D; Carcelain G; Ravaud P
    Ann Rheum Dis; 2012 Nov; 71(11):1783-90. PubMed ID: 22258485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in diagnosing latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.
    Keystone EC; Papp KA; Wobeser W
    J Rheumatol; 2011 Jul; 38(7):1234-43. PubMed ID: 21459944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and management of latent tuberculosis infections before biologic therapy for psoriasis.
    Amerio P; Amoruso G; Bardazzi F; Campanati A; Cassano N; Conti A; Gisondi P; Guarneri C; Mazzotta A; Piaserico S; Prestinari F; Prignano F; Zane C; de Simone C
    J Dermatolog Treat; 2013 Aug; 24(4):305-11. PubMed ID: 22208431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test.
    Laffitte E; Janssens JP; Roux-Lombard P; Thielen AM; Barde C; Marazza G; Panizzon RG; Saurat JH
    Br J Dermatol; 2009 Oct; 161(4):797-800. PubMed ID: 19659473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the tuberculin skin test and interferon-γ release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches.
    Goletti D; Sanduzzi A; Delogu G
    J Rheumatol Suppl; 2014 May; 91():24-31. PubMed ID: 24788997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis screening prior to anti-tumor necrosis factor therapy among patients with immune-mediated inflammatory diseases in Japan: a longitudinal study using a large-scale health insurance claims database.
    Tomio J; Yamana H; Matsui H; Yamashita H; Yoshiyama T; Yasunaga H
    Int J Rheum Dis; 2017 Nov; 20(11):1674-1683. PubMed ID: 29076252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon gamma release assays: principles and practice.
    Lalvani A; Pareek M
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.
    Park JH; Seo GY; Lee JS; Kim TH; Yoo DH
    J Rheumatol; 2009 Oct; 36(10):2158-63. PubMed ID: 19723901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of indeterminate IFN-γ release assay in screening for latent TB in inflammatory bowel diseases.
    Papay P; Eser A; Winkler S; Frantal S; Primas C; Miehsler W; Angelberger S; Novacek G; Mikulits A; Vogelsang H; Reinisch W
    Eur J Clin Invest; 2011 Oct; 41(10):1071-6. PubMed ID: 21413978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis.
    Chen DY; Shen GH; Chen YM; Chen HH; Lin CC; Hsieh CW; Lan JL
    Int J Tuberc Lung Dis; 2011 Feb; 15(2):192-200. PubMed ID: 21219680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay.
    Dinser R; Fousse M; Sester U; Albrecht K; Singh M; Köhler H; Müller-Ladner U; Sester M
    Rheumatology (Oxford); 2008 Feb; 47(2):212-8. PubMed ID: 18208824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour necrosis factor antagonist and tuberculosis in patients with rheumatoid arthritis: an Asian perspective.
    To KW; Reino JJ; Yoo DH; Tam LS
    Respirology; 2013 Jul; 18(5):765-73. PubMed ID: 23627398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miliary tuberculosis following negative latent tuberculosis infection screening prior to tumor necrosis factor-α antagonists: implications for management?
    Teh BW; Street AC; McBryde ES; Denholm JT
    J Rheumatol; 2012 Jun; 39(6):1297-8. PubMed ID: 22661422
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis of tuberculosis in dialysis patients: current strategy.
    Segall L; Covic A
    Clin J Am Soc Nephrol; 2010 Jun; 5(6):1114-22. PubMed ID: 20413440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma release assay test characteristics depend upon the prevalence of active tuberculosis.
    Davidow AL
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1411-5. PubMed ID: 19861015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.